[1]曹 非,王 艳,郭 志,等.氩氦冷冻消融治疗鼻咽癌肝转移16例 [J].介入放射学杂志,2019,28(03):247-251.
 CAO Fei,WANG Yan,GUO Zhi,et al.Argon- helium cryoablation for the treatment of hepatic metastases from nasopharyngeal carcinoma: initial results in 16 patients[J].journal interventional radiology,2019,28(03):247-251.
点击复制

氩氦冷冻消融治疗鼻咽癌肝转移16例
()

PDF下载中关闭

分享到:

《介入放射学杂志》[ISSN:1008-794X/CN:31-1796/R]

卷:
28
期数:
2019年03期
页码:
247-251
栏目:
非血管介入
出版日期:
2019-03-25

文章信息/Info

Title:
Argon- helium cryoablation for the treatment of hepatic metastases from nasopharyngeal carcinoma: initial results in 16 patients
作者:
曹 非 王 艳 郭 志 于海鹏 杨雪玲 司同国
Author(s):
CAO Fei WANG Yan GUO Zhi YU Haipeng YANG Xueling SI Tongguo.
Department of Interventional Therapy, Cancer Hospital of Tianjin Medical University, National Clinical Research Center of Cancer, Key Laboratory of Cancer Prevention and Therapy of Tianjin, Tianjin 300060, China
关键词:
【关键词】 鼻咽癌 肝转移瘤 冷冻消融
文献标志码:
A
摘要:
【摘要】 目的 探讨CT引导下经皮穿刺氩氦冷冻消融治疗鼻咽癌肝转移瘤的安全性及疗效。方法回顾分析16例行经皮穿刺氩氦冷冻消融治疗鼻咽癌肝转移瘤患者的临床资料,观察术前术后患者生活质量及术后并发症,统计患者冷冻术后疾病无进展生存时间(PFS)、总生存期(OS)、术后1、3、6和12个月肿瘤局部控制率。结果 所有患者冷冻消融治疗术后均未出现严重并发症且生活质量明显提高,术后1、3、6和12个月肿瘤局部控制率分别为100%、87.5%,80.0%,58.3%,PFS为11个月(95%CI:8.4~13.6个月),中位OS为19个月(95%CI:9.2~28.8个月),术后半年、1年及2年生存率分别为93.8%、75%及43.8%。结论 CT引导下经皮穿刺氩氦冷冻消融治疗鼻咽癌肝转移瘤疗效确切,创伤微小,安全有效。

参考文献/References:

[1] Zhang LF, Li YH, Xie SH, et al. Incidence trend of nasopharyngeal carcinoma from 1987 to 2011 in Sihui County, Guangdong Province, South China: an age- period- cohort analysis[J]. Chin J Cancer, 2015, 34: 350- 357.
[2] Wu L, Li C, Pan L. Nasopharyngeal carcinoma: a review of current updates[J]. Exp Ther Med, 2018, 15: 3687- 3692.
[3] Shen LJ, Wang SY, Xie GF, et al. Subdivision of M category for nasopharyngeal carcinoma with synchronous metastasis: time to expand the M categorization system[J]. Chin J Cancer, 2015, 34: 450- 458.
[4] Li W, Bai YT, Wu LJ, et al. Combined CT- guided radiofrequency ablation with systemic chemotherapy improves the survival for nasopharyngeal carcinoma with oligometastasis in liver: propensity score matching analysis[J]. Oncotarget, 2017, 8: 52132- 52141.
[5] Ditto A, Martinelli F, Bogani G, et al. Fertility- sparing surgery in early- stage cervical cancer patients: oncologic and reproductive outcomes[J]. Int J Gynecol Cancer, 2015, 25: 493- 497.
[6] Greene FL, Sobin LH. The staging of cancer: a retrospective and prospective appraisal[J]. CA Cancer J Clin, 2008, 58: 180- 190.
[7] Gospodarowicz MK, Miller D, Groome PA, et al. The process for continuous improvement of the TNM classification[J]. Cancer, 2004, 100: 1- 5.
[8] Leung SF, Teo PM, Shiu WW, et al. Clinical features and management of distant metastases of nasopharyngeal carcinoma[J]. J Otolaryngol, 1991, 20: 27- 29.
[9] Hui EP, Leung SF, Au JS, et al. Lung metastasis alone in nasopharyngeal carcinoma: a relatively favorable prognostic group. A study by the Hong Kong Nasopharyngeal Carcinoma Study Group[J]. Cancer, 2004, 101: 300- 306.
[10] Liu, F, Jin T, Liu L, et al. The role of concurrent chemotherapy for stage Ⅱ nasopharyngeal carcinoma in the intensity- modulated radiotherapy era: a systematic review and meta- analysis[J]. PLoS One, 2018, 13: e0194733.
[11] Zhang W, Yu H, Guo Z, et al. Percutaneous cryoablation of liver metastases from breast cancer: initial experience in 17 patients[J]. Clin Radiol, 2014, 69: 231- 238.
[12] Gao W, Guo Z, Zhang X, et al. Percutaneous cryoablation of ovarian cancer metastasis to the liver initial experience in 13 patients[J]. Int J Gynecol Cancer, 2015, 25: 802- 808.
[13] Li Z, Fu Y, Li Q, et al. Cryoablation plus chemotherapy in colorectal cancer patients with liver metastases[J]. Tumor Biol, 2014, 35: 10841- 10848.
[14] 常 旭, 郭 志, 于海鹏, 等. 氩氦刀冷冻消融挽救治疗胃癌肝转移患者[J]. 介入放射学杂志, 2018, 27: 40- 44.
[15] Bensouda Y, Kaikani W, Ahbeddou N, et al. Treatment for metastatic nasopharyngeal carcinoma[J]. Eur Ann Otorhino- laryngol Head Neck Dis, 2011, 128: 79- 85.
[16] Chen YP, Tang LL, Yang Q, et al. Induction chemotherapy plus concurrent chemoradiotherapy in endemic nasopharyngeal carcinoma: individual patient data pooled analysis of four randomized trials[J]. Clin Cancer Res, 2018, 24: 1824- 1833.
[17] 唐 田, 古善智, 李国文, 等. 经皮微波消融治疗鼻咽癌局限肝转移的疗效分析[J]. 中国癌症杂志, 2016, 26: 943- 946.
[18] Pan C, He N, Zhao M, et al. Subdividing the M1 stage of liver metastasis for nasopharyngeal carcinoma to better predict metastatic survival[J]. Med Oncol, 2011, 28: 1349- 1355.

相似文献/References:

[1]刘 晟,沈 强,许 赟,等.微波消融治疗结直肠癌根治术后肝转移患者的疗效分析[J].介入放射学杂志,2016,(08):689.
 LIU Sheng,SHEN Qiang,XU Yun,et al.Microwave ablation for the treatment of colorectal liver metastases after radical surgery: analysis of its curative effect [J].journal interventional radiology,2016,(03):689.
[2]敖 劲,杨孔武,穆茂媛,等.微粒-TACE联合伊马替尼治疗进展期胃肠道间质瘤肝转移临床疗效观察[J].介入放射学杂志,2020,29(08):820.
 AO Jin,YANG Kongwu,MU Maoyuan,et al.TACE with gelatin sponge microparticles combined with imatinib for liver metastases from advanced gastrointestinal stromal tumors: clinical observation of curative effect[J].journal interventional radiology,2020,29(03):820.
[3]林志鹏,邹旭公,胡小龙,等.鼻咽癌患者放疗后颈内动脉假性动脉瘤破裂大出血介入治疗效果分析[J].介入放射学杂志,2023,32(09):881.
 LIN Zhipeng,ZOU Xugong,HU Xiaolong,et al.Interventional therapy for the rupture of internal carotid artery pseudoaneurysm with massive bleeding in patients with nasopharyngeal carcinoma after receiving radiotherapy: analysis of the clinical effect[J].journal interventional radiology,2023,32(03):881.
[4]刘宇洲,孙 林,向 斌,等.介入止血在鼻咽癌放疗后大出血治疗中的应用[J].介入放射学杂志,2023,32(02):145.
 LIU Yuzhou,SUN Lin,XIANG Bin,et al.Application of interventional hemostatic therapy in the treatment of massive hemorrhage after radiotherapy for nasopharyngeal carcinoma[J].journal interventional radiology,2023,32(03):145.

备注/Memo

备注/Memo:
(收稿日期:2018-05-08)
(本文编辑:俞瑞纲)
更新日期/Last Update: 2019-03-20